SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $87 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
Q1 2021 | $342,000 | -68.3% | 4,589 | -27.5% | 0.25% | -70.7% |
Q4 2020 | $1,079,000 | +53.3% | 6,330 | +26.3% | 0.86% | +32.9% |
Q3 2020 | $704,000 | -31.7% | 5,013 | -22.0% | 0.65% | -36.6% |
Q2 2020 | $1,031,000 | +35.8% | 6,427 | -17.2% | 1.02% | +12.1% |
Q1 2020 | $759,245 | -32.9% | 7,762 | -11.4% | 0.91% | -16.6% |
Q4 2019 | $1,131,000 | – | 8,761 | – | 1.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |